5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review.

The enzyme 5,10-methylenetetrahydrofolate reductase (MTHFR) is involved in folate metabolism. The MTHFR gene is located on chromosome 1 (1p36.3), and two common alleles, the C677T (thermolabile) allele and the A1298C allele, have been described. The population frequency of C677T homozygosity ranges from 1% or less among Blacks from Africa and the United States to 20% or more among Italians and US Hispanics. C677T homozygosity in infants is associated with a moderately increased risk for spina bifida (pooled odds ratio = 1.8; 95% confidence interval: 1.4, 2.2). Maternal C677T homozygosity also appears to be a moderate risk factor (pooled odds ratio = 2.0; 95% confidence interval: 1.5, 2.8). The A 1298C allele combined with the C677T allele also could be associated with an increased risk for spina bifida. Some data suggest that the risk for spina bifida associated with C677T homozygosity may depend on nutritional status (e.g., blood folate levels, intake of vitamins) or on the genotype of other folate-related genes (e.g., cystathionine-beta-synthase and methionine synthase reductase). Studies of the C677T allele in relation to oral clefts, Down syndrome, and fetal anticonvulsant syndrome either have yielded conflicting results or have not been yet replicated.

[1]  P. Froguel,et al.  The (Ala-Val) mutation of methylenetetrahydrofolate reductase as a genetic risk factor for vascular disease in non-insulin-dependent diabetic patients. , 1997, American journal of human genetics.

[2]  S. Vollset,et al.  Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study. , 1996, The Journal of clinical investigation.

[3]  J. Buring,et al.  Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-control study. , 1996, Circulation.

[4]  E. Trabetti,et al.  Methylenetetrahydrofolate Reductase C677T Mutation, Plasma Homocysteine, and Folate in Subjects From Northern Italy With or Without Angiographically Documented Severe Coronary Atherosclerotic Disease: Evidence for an Important Genetic-Environmental Interaction , 1998 .

[5]  D. Wilcken,et al.  Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[6]  Tsuyoshi Watanabe,et al.  Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients , 1998, The Lancet.

[7]  H. Blom,et al.  Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? , 1994, Metabolism: clinical and experimental.

[8]  D. Yoder.  Preventing neural tube defects with folic acid. , 1999, Tennessee medicine : journal of the Tennessee Medical Association.

[9]  P. Goyette,et al.  Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of five novel mutations in MTHFR. , 1996, American journal of human genetics.

[10]  G. Shaw,et al.  Analysis of select folate pathway genes, PAX3, and human T in a Midwestern neural tube defect population. , 1999, Teratology.

[11]  R. Macko,et al.  Thermolabile methylenetetrahydrofolate reductase polymorphism (C677T) and total homocysteine concentration among African-American and white women. , 1998, Ethnicity & disease.

[12]  J. Burn,et al.  Methylenetetrahydrofolate reductase and neural tube defects , 1996, The Lancet.

[13]  A. Marian,et al.  A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction. , 1997, Atherosclerosis.

[14]  A. Gnasso,et al.  Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine and other risk factors for vascular disease. , 1998, Atherosclerosis.

[15]  D. Knook,et al.  Mortality risk in men is associated with a common mutation in the methylenetetrahydrofolate reductase gene (MTHFR) , 1999, European Journal of Human Genetics.

[16]  Zhoutao Chen,et al.  Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR) , 1998, Mammalian Genome.

[17]  Y. Yazaki,et al.  Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[18]  J. Mills,et al.  Homocysteine metabolism in pregnancies complicated by neural-tube defects , 1995, The Lancet.

[19]  A. Viel,et al.  Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas. , 1997, British Journal of Cancer.

[20]  P. Mannucci,et al.  A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506). , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[21]  B. Giusti,et al.  Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase. , 1998, American journal of human genetics.

[22]  T. Arinami,et al.  Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. , 1997, Journal of medical genetics.

[23]  D. Shields,et al.  The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. , 1999, American journal of human genetics.

[24]  D. Pearl,et al.  The incidence of the gene for thermolabile methylene tetrahydrofolate reductase in African Americans. , 1996, Thrombosis research.

[25]  P. Collins,et al.  Factor V Leiden (G1691A), the prothrombin 3'-untranslated region variant (G20210A) and thermolabile methylenetetrahydrofolate reductase (C677T): a single genetic test genotypes all three loci--determination of frequencies in the S. Wales population of the UK. , 1998, Thrombosis and haemostasis.

[26]  M. Margaglione,et al.  Elevated total plasma homocysteine and 677C-->T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease. , 1996, American journal of human genetics.

[27]  H. Blom,et al.  The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. , 1997, Atherosclerosis.

[28]  R. Matthews,et al.  Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification , 1994, Nature Genetics.

[29]  F. Costa,et al.  Prevalence of the mutation C677 --> T in the methylene tetrahydrofolate reductase gene among distinct ethnic groups in Brazil. , 1998, American journal of medical genetics.

[30]  F. Costa,et al.  The Mutation Ala677→Val in the Methylene Tetrahydrofolate Reductase Gene: A Risk Factor for Arterial Disease and Venous Thrombosis , 1997, Thrombosis and Haemostasis.

[31]  M. Norusis,et al.  Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. , 1991, American journal of human genetics.

[32]  T. Arinami,et al.  Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study. , 1998, Atherosclerosis.

[33]  P. Mastroiacovo,et al.  Exploring gene—gene interactions in the etiology of neural tube defects , 1998, Clinical genetics.

[34]  R. Rozen,et al.  A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. , 1999, Molecular genetics and metabolism.

[35]  I. Rosenberg,et al.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. , 1996, Circulation.

[36]  Y. Yazaki,et al.  Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. , 1997, Circulation.

[37]  J. Mills,et al.  Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: low folate status alone may be the critical factor. , 1998, American journal of medical genetics.

[38]  R. Rozen.  Genetic Predisposition to Hyperhomocysteinemia: Deficiency of Methylenetetrahydrofolate Reductase (MTHFR) , 1997, Thrombosis and Haemostasis.

[39]  N. Wenger,et al.  Relation of three genetic traits to venous thrombosis in an African-American population. , 1998, American journal of epidemiology.

[40]  H. Arai,et al.  The frequency of the methylenetetrahydrofolate reductase-gene mutation varies with age in the normal population. , 1997, American journal of human genetics.

[41]  M. Margaglione,et al.  The Methylenetetrahydrofolate Reductase TT677 Genotype Is Associated with Venous Thrombosis Independently of the Coexistence of the FV Leiden and the Prothrombin , 1998, Thrombosis and Haemostasis.

[42]  V. Gudnason,et al.  C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. EARS group. , 1997, Atherosclerosis.

[43]  C Y Ou,et al.  5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. , 1996, American journal of medical genetics.

[44]  B. Giusti,et al.  Frequency of Factor V (FV) Leiden and C677T Methylenetetrahydrofolate Reductase (MTHFR) Mutations in Colombians , 1998, Thrombosis and Haemostasis.

[45]  F. Solehdin,et al.  Folic acid for the prevention of congenital anomalies , 1998, European Journal of Pediatrics.

[46]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[47]  E. Rimm,et al.  A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: results among U.S. men. , 1998, Journal of the American College of Cardiology.

[48]  R. Rozen,et al.  Decreased proportion of female newborn infants homozygous for the 677 C-->T mutation in methylenetetrahydrofolate reductase. , 1999, American journal of medical genetics.

[49]  M. Gnant,et al.  Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study , 1991, The Lancet.

[50]  F. Gabreëls,et al.  A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? , 1998, American journal of human genetics.

[51]  J. Clegg,et al.  Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. , 1998, American journal of human genetics.

[52]  K. Kario,et al.  A common mutation in methylenetetrahydrofolate reductase gene among the Japanese population , 1996, Japanese Journal of Human Genetics.

[53]  J. Carlquist,et al.  A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction. , 1997, Journal of the American College of Cardiology.

[54]  V. L. Wilson,et al.  Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. , 1999, The American journal of clinical nutrition.

[55]  A. Ziegler,et al.  Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population , 1998, European Journal of Pediatrics.

[56]  H. Markus,et al.  A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. , 1997, Stroke.

[57]  M. den Heyer,et al.  Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida , 1995, The Lancet.

[58]  R. Abbate,et al.  The High Prevalence of Thermolabile 5-10 Methylenetetrahydrofolate Reductase (MTHFR) in Italians Is not Associated to an Increased Risk for Coronary Artery Disease (CAD) , 1998, Thrombosis and Haemostasis.

[59]  D. Rosenblatt.  Inherited disorders of folate transport and metabolism , 1989 .

[60]  E. Sacchi,et al.  High Frequency of the C677T Mutation in the Methylenetetrahydrofolate Reductase (MTHFR) Gene in Northern Italy , 1997, Thrombosis and Haemostasis.

[61]  H. Blom,et al.  Is the common 677C-->T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. , 1997, QJM : monthly journal of the Association of Physicians.

[62]  R. Rozen,et al.  A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. , 1998, Molecular genetics and metabolism.

[63]  M. P. Sperandeo,et al.  The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy. , 1998, Journal of medical genetics.

[64]  G. Shaw,et al.  Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. , 1998, American journal of epidemiology.

[65]  E. Rimm,et al.  A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. , 1996, Cancer research.

[66]  W. Willett,et al.  Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. , 1996, Circulation.

[67]  B. Warf,et al.  Neural-tube defects. , 1978, Lancet.

[68]  M. Margaglione,et al.  Thrombophilic Genotypes in Subjects with Idiopathic Antiphospholipid Antibodies – Prevalence and Significance , 1998, Thrombosis and Haemostasis.

[69]  S. Daly,et al.  Thermolabile variant of 5, 10-methylenetetrahydrofolate reductaseassociated with low red-cell folates: implications for folate intake recommendations , 1997, The Lancet.

[70]  Y. Yazaki,et al.  [Gene Polymorphism of 5, 10-methylenetetrahydrofolate reductase as a coronary risk factor]. , 1997, Journal of cardiology.

[71]  J. Mulinare,et al.  International Clearinghouse for Birth Defects Monitoring Systems, 24th Annual Meeting, November 19th, 1997: The occurrence of heart defects in relation to maternal use of multivitamins in the periconceptional period , 1998 .

[72]  M. Zago,et al.  Analysis of the 677 C→T Mutation of the Methylenetetrahydrofolate Reductase Gene in Different Ethnic Groups , 1998, Thrombosis and Haemostasis.

[73]  P. Frosst,et al.  Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. , 1996, American journal of human genetics.

[74]  P. Collins,et al.  Factor V Leiden (G1691A), the Prothrombin 3’-Untranslated Region Variant (G20210A) and Thermolabile Methylenetetrahydrofolate Reductase (C677T): A Single Genetic Test Genotypes all Three Loci – Determination of Frequencies in the S. Wales Population of the UK , 1998, Thrombosis and Haemostasis.

[75]  F. Muller,et al.  Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects , 1997, Human Genetics.

[76]  J. Kastelein,et al.  Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. , 1997, Circulation.

[77]  A. Evans,et al.  Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation. , 1996, Circulation.

[78]  P. Romano,et al.  The Cost of Birth Defects: Estimates of the Value of Protection , 1996 .

[79]  J. Mills,et al.  Methylenetetrahydrofolate reductase mutation and neural tube defects , 1996, The Lancet.

[80]  D. Weir,et al.  Are common mutations of cystathionine β‐synthase involved in the aetiology of neural tube defects? , 1997, Clinical genetics.

[81]  L. Lannfelt,et al.  A methylenetetrahydrofolate reductase gene polymorphism in ischaemic stroke and in carotid artery stenosis , 1998, European journal of clinical investigation.

[82]  T. George,et al.  The thermolabile variant of methylenetetrahydrofolate reductase (MTHFR) is not a major risk factor for neural tube defect in American Caucasians , 1997, Neurogenetics.

[83]  A. Tosetto,et al.  The VITA Project: C677T mutation in the methylene‐tetrahydrofolate reductase gene and risk of venous thromboembolism , 1997, British journal of haematology.

[84]  Reinhardt,et al.  Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and the risk of coronary artery disease , 1998, European journal of clinical investigation.

[85]  W. Willett,et al.  Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. , 1997, Cancer research.

[86]  L. Taylor,et al.  Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. , 1996, Circulation.

[87]  P. Frosst,et al.  Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. , 1995, American journal of human genetics.

[88]  J. Burn,et al.  Susceptibility to spina bifida; an association study of five candidate genes , 1998, Annals of human genetics.

[89]  C. Hay,et al.  The C677T MTHFR variant and the risk of venous thrombosis. , 1997, British journal of haematology.

[90]  G. Shaw,et al.  Infant C677T mutation in MTHFR, maternal periconceptional vitamin use, and cleft lip. , 1998, American journal of medical genetics.

[91]  P. Ueland,et al.  Elevated plasma total homocysteine and C677T mutation of the methylenetetrahydrofolate reductase gene in patients with spina bifida. , 1997, QJM : monthly journal of the Association of Physicians.

[92]  J. Selhub,et al.  Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[93]  T. Arinami,et al.  Methylenetetrahydrofolate reductase variant and schizophrenia/depression. , 1997, American journal of medical genetics.

[94]  J. Yarnell,et al.  The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. , 1996, QJM : monthly journal of the Association of Physicians.

[95]  D C Shields,et al.  A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. , 1995, QJM : monthly journal of the Association of Physicians.

[96]  A. Czeizel,et al.  Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. , 1992, The New England journal of medicine.

[97]  J. Higaki,et al.  Methylenetetrahydrofolate reductase gene polymorphism: relation to blood pressure and cerebrovascular disease. , 1998, American journal of hypertension.

[98]  R. Rozen,et al.  Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. , 1999, American journal of medical genetics.

[99]  N. Samani,et al.  Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction. , 1996, QJM : monthly journal of the Association of Physicians.

[100]  P. Turnpenny,et al.  Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene , 1999, Clinical genetics.

[101]  J. Mills,et al.  Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. , 1999, American journal of medical genetics.

[102]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .

[103]  P. Frosst,et al.  Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[104]  R. Stevenson,et al.  Differences in methylenetetrahydrofolate reductase genotype frequencies, between Whites and Blacks. , 1997, American journal of human genetics.

[105]  J. Mulinare,et al.  Re: "Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida". , 1999, American journal of epidemiology.

[106]  M. Margaglione,et al.  Presence of FV Leiden and MTHFR Mutation in a Patient with Complicated Pregnancies , 1997, Thrombosis and Haemostasis.

[107]  B. Anar,et al.  677→CT mutation on the methylenetetrahydrofolate reductase gene is not a risk factor for neural tube defects in Turkey , 1998, Archives of disease in childhood. Fetal and neonatal edition.

[108]  T. Raghunathan,et al.  Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. , 1997, Circulation.